{"code":"Q2043","short_description":"Sipuleucel-t auto cd54+","long_description":"Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion","status":"active","section":"Q-codes: Temporary Codes","category":"Temporary","effective_date":"2011-07-01","termination_date":null,"replacement_code":"","opps_status_indicator":"K","opps_status_label":"Non-pass-through drugs and biologicals","opps_apc":"9273","fee_schedules":[],"mue":[{"service_type":"practitioner","mue_value":1,"adjudication_indicator":"2","adjudication_description":"Date of Service Edit: Policy","edit_rationale":"Code Descriptor \/ CPT Instruction"},{"service_type":"outpatient","mue_value":1,"adjudication_indicator":"2","adjudication_description":"Date of Service Edit: Policy","edit_rationale":"Code Descriptor \/ CPT Instruction"}],"drug_classes":[],"ndc_crosswalk":[{"ndc":"30237-8900-06","drug_name":"Provenge","dosage":"Per infusion (minimum 50 million cells)","unit":"1","labeler_name":"Dendreon Pharmaceuticals LLC"}],"utilization":[],"urls":{"self_html":"https:\/\/hcpcslookup.com\/codes\/q2043","self_json":"https:\/\/hcpcslookup.com\/api\/codes\/Q2043.json"}}